Wikidata

(Q45095081)

English

Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status

scientific article published in October 2004

In more languages

Statements

title
Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017
author name string
Mitsushige Sugimoto
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017
Takahisa Furuta
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017
Naohito Shirai
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017
Masayoshi Kajimura
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017
Akira Hishida
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017
Masaharu Sakurai
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017
Kyoichi Ohashi
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017
Takashi Ishizaki
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017
publication date
1 October 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017
page(s)
290-301
1 reference
stated in
Europe PubMed Central
PubMed ID
15470328
retrieved
9 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q45095081&oldid=2065596624"